| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |